Emerging neurological biomarkers enabling personalized care is fastest growing segment fueling the growth of Neurological Biomarkers Market
The global Neurological Biomarkers Market is estimated to be valued at US$ 11813.64 Mn in 2023 and is expected to exhibit a CAGR of 14% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Neurological biomarkers are indicators of normal or pathogenic biological processes measured from body fluids or tissues that assist in the evaluation of neurological status and progression. They aid in various processes associated with neurological disorders including diagnosis, monitoring disease progression, and assessing response to treatment. Market key trends: One of the key trends fueling the growth of this market is the ability of neurological biomarkers to enable precision and personalized medicine. Biomarkers are being used for preclinical diagnosis, risk assessment, prognosis, and tailored treatment approaches for neurological conditions. They help identify patient subtypes and endophenotypes based on molecular s...